Nutley, NJ, United States of America

Joseph Anthony Bilotta

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Astoria, NY (US) (2009)
  • Nutley, NJ (US) (2013 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovator - Joseph Anthony Bilotta

Introduction: Joseph Anthony Bilotta, a talented inventor hailing from Nutley, NJ (US), has made significant contributions to the field of antiviral compounds. With a total of 4 patents under his belt, Bilotta's innovative spirit and dedication to research have left a mark on the pharmaceutical industry.

Latest Patents: Bilotta's latest patents revolve around antiviral compounds aimed at combating HCV infection. The compounds of Formula I, as described in his inventions, showcase novel pharmaceutical compositions with promising potential in the prevention and treatment of HCV infection.

Career Highlights: Currently employed at Hoffmann-La Roche Inc., Bilotta has been instrumental in driving forward groundbreaking research in antiviral therapeutics. His expertise in medicinal chemistry has led to the development of patented compounds that hold immense promise in the fight against infectious diseases.

Collaborations: Throughout his career, Bilotta has collaborated closely with esteemed coworkers Eric Mertz and Kevin Richard Guertin. Together, they have synergized their skills and knowledge to push the boundaries of pharmaceutical innovation, resulting in the successful patenting of novel antiviral compounds.

Conclusion: Joseph Anthony Bilotta's dedication to advancing antiviral research and his prolific patent portfolio exemplify his unwavering commitment to scientific excellence. His contributions to the field continue to inspire and pave the way for future breakthroughs in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…